tiprankstipranks
Clovis Oncology (CLVSQ)
OTHER OTC:CLVSQ

Clovis Oncology (CLVSQ) Stock Investors

0 Followers
Based on 663,819 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CLVSQ
On average, investors allocate 2.24% of their portfolios to CLVSQ
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 663,819 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CLVSQ

1.1%
Last 7
Days
4.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CLVSQ, out of 663,819 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CLVSQ Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.17%
$0.12
Based on the activity of 12,402 investors who made their portfolios public
The table shows changes in CLVSQ in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CLVSQ Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.42%
+0.49%
+0.54%
46.92B
Healthcare
General Electric
5.60%
+0.11%
-0.62%
120.36B
Industrials
DraftKings
6.25%
+0.05%
+0.25%
24.67B
Technology
Nikola
5.75%
-0.02%
+2.73%
1.06B
Energy
Blink Charging Co
4.00%
+0.53%
+2.26%
415.45M
Utilities
Twilio
3.09%
-0.20%
-1.37%
11.69B
Technology
Barrick Gold
6.18%
+0.12%
-0.12%
29.04B
Basic Materials
AMC Entertainment
5.88%
-0.14%
-1.78%
6.42B
Consumer Cyclical
Micron
5.54%
+0.71%
+1.90%
68.43B
Technology
Syros Pharmaceuticals
3.68%
-1.17%
-6.04%
62.40M
Healthcare
Based on the activity of 663,819 active portfolios
Open your Smart Portfolio

CLVSQ Investor Analysis

CLVSQ investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
20.3%
of CLVSQ holders
are under 35
Average Segment Performance
Average P/E Ratio35.74
Beta11.13
Dividend Yield4.33%
CLVSQ investors between 35–55

Between 35–55

2.6%
Last 30 days
Holdings Change
60.8%
of CLVSQ holders
are between 35–55
Average Segment Performance
Average P/E Ratio37.85
Beta14.34
Dividend Yield4.58%
CLVSQ investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
18.9%
of CLVSQ holders
are over 55
Average Segment Performance
Average P/E Ratio37.66
Beta5.41
Dividend Yield4.64%
Overview of age group and performance of CLVSQ stock investors
See who invests in CLVSQ according to age group and performance.

FAQ

How many retail Investors hold CLVSQ?
<0.1% of TipRanks' retail investors hold CLVSQ in their portfolios.
    What is CLVSQ Investor Sentiment?
    CLVSQ’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CLVSQ in the last 7 days?
      ▼ 1.1% of TipRanks' retail investors changed their holding of CLVSQ in the last 7 days.
        What percentage of retail investors changed their holding of CLVSQ in the last 30 days?
        ▼ 4.8% of TipRanks' retail investors changed their holding of CLVSQ in the last 30 days.
          What is the average age of retail investors who hold CLVSQ?
          The average age of CLVSQ Holders is between 35–55.
            What other stocks have CLVSQ investors also bought?
            CLVSQ Investors also bought MRNA, GE, DKNG, NKLA, BLNK, TWLO, GOLD, AMC, MU, SYRS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ATECAlphatec Holdings
              AZNAstraZeneca
              BIIBBiogen
              BLRXBioline RX Ltd Sponsored ADR
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis